| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Prolyl hydroxylase EGLN2 |
|---|
| Ligand | BDBM118333 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | Inhibition Assay |
|---|
| IC50 | 780±n/a nM |
|---|
| Citation |  Thede, K; Flamme, I; Oehme, F; Ergüden, J; Stoll, F; Schuhmacher, J; Wild, H; Kolkhof, P; Beck, H; Keldenich, J; Akbaba, M; Jeske, M Substituted dihydropyrazolones for treating cardiovascular and hematological diseases US Patent US8653111 Publication Date 2/18/2014 |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Prolyl hydroxylase EGLN2 |
|---|
| Name: | Prolyl hydroxylase EGLN2 |
|---|
| Synonyms: | EGLN2 | EGLN2_HUMAN | EIT6 | Egl nine homolog 2 | Estrogen-induced tag 6 | HIF prolyl hydroxylase | HIF-PH1 | HIF-prolyl hydroxylase 1 | HPH-3 | Hypoxia-inducible factor prolyl hydroxylase | PHD1 | Prolyl hydroxylase domain-containing protein 1 | Prolyl hydroxylase domain-containing protein 1 (PHD1) |
|---|
| Type: | Protein |
|---|
| Mol. Mass.: | 43657.01 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | Q96KS0 |
|---|
| Residue: | 407 |
|---|
| Sequence: | MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAG
SGTPRATATSTTASPLRDGFGGQDGGELRPLQSEGAAALVTKGCQRLAAQGARPEAPKRK
WAEDGGDAPSPSKRPWARQENQEAEREGGMSCSCSSGSGEASAGLMEEALPSAPERLALD
YIVPCMRYYGICVKDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQI
AWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYVINGRTKAMVACYPGNGLGYVRHVDN
PHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEV
KPAYATRYAITVWYFDAKERAAAKDKYQLASGQKGVQVPVSQPPTPT
|
|
|
|---|
| BDBM118333 |
|---|
| n/a |
|---|
| Name | BDBM118333 |
|---|
| Synonyms: | US8653111, 45 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C14H16N6O2 |
|---|
| Mol. Mass. | 300.3158 |
|---|
| SMILES | CC(C)c1cn(nn1)-c1c[nH]n(-c2ccc(CO)cn2)c1=O |
|---|
| Structure | 
|
|---|
Search and Browse
